XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segments
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Segments

Note 15 – Segments

 

Segment identification and selection is consistent with the management structure used by the Company’s chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company’s management structure and method of internal reporting, the Company has one operating segment. The Company’s chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

 

Net sales attributed to customers in the United States and foreign countries for the three months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
United States   $ 9,242,986     $ 8,475,694  
Foreign countries     485,726       843,224  
    $ 9,728,712     $ 9,318,918  

 

Foreign countries primarily consist of Australia and Canada.

 

The Company’s net sales by product group for the three months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
Nutraceuticals   $ 8,895,489     $ 6,618,264  
Over the Counter (OTC)     171,918       572,014  
Consumer Goods     290,641       2,041,087  
Cosmeceuticals     370,664       87,553  
    $ 9,728,712     $ 9,318,918  

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

The Company’s net sales by major sales channel for the three months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
Online   $ 3,611,997     $ 5,479,297  
Retail     6,116,715       3,839,621  
    $ 9,728,712     $ 9,318,918  

 

Net sales attributed to customers in the United States and foreign countries for the six months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
United States   $ 18,270,848     $ 18,420,847  
Foreign countries     1,158,725       1,686,390  
    $ 19,429,573     $ 20,107,237  

 

The Company’s net sales by product group for the six months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
Nutraceuticals   $ 17,910,268     $ 16,164,707  
Over the Counter (OTC)     334,102       1,075,693  
Consumer Goods     562,932       2,772,634  
Cosmeceuticals     622,271       94,203  
    $ 19,429,573     $ 20,107,237  

 

(1) Net sales for any other product group of similar products are less than 10% of consolidated net sales.

 

The Company’s net sales by major sales channel for the six months ended June 30, 2018 and 2017 were as follows:

 

    June 30, 2018     June 30, 2017  
Online   $ 9,024,597     $ 11,460,053  
Retail     10,404,976       8,647,184  
    $ 19,429,573     $ 20,107,237  

 

Long-lived assets (net) attributable to operations in the United States and foreign countries as of June 30, 2018 and December 31, 2017 were as follows:

 

    June 30, 2018     December 31, 2017  
United States   $ 12,890,912     $ 13,613,043  
Foreign countries     14,607       5,612  
    $ 12,905,519     $ 13,618,655